nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—ABCB1—Ticagrelor—coronary artery disease	0.0611	0.13	CbGbCtD
Amantadine—ABCB1—Clopidogrel—coronary artery disease	0.0378	0.0805	CbGbCtD
Amantadine—ABCB1—Perindopril—coronary artery disease	0.0378	0.0805	CbGbCtD
Amantadine—ABCB1—Telmisartan—coronary artery disease	0.033	0.0704	CbGbCtD
Amantadine—ABCB1—Pitavastatin—coronary artery disease	0.033	0.0704	CbGbCtD
Amantadine—ABCB1—Lisinopril—coronary artery disease	0.0313	0.0667	CbGbCtD
Amantadine—ABCB1—Enalapril—coronary artery disease	0.0313	0.0667	CbGbCtD
Amantadine—ABCB1—Timolol—coronary artery disease	0.0266	0.0567	CbGbCtD
Amantadine—ABCB1—Ezetimibe—coronary artery disease	0.0243	0.0519	CbGbCtD
Amantadine—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0237	0.0506	CbGbCtD
Amantadine—ABCB1—Captopril—coronary artery disease	0.0234	0.05	CbGbCtD
Amantadine—ABCB1—Simvastatin—coronary artery disease	0.0226	0.0482	CbGbCtD
Amantadine—ABCB1—Lovastatin—coronary artery disease	0.0221	0.0472	CbGbCtD
Amantadine—ABCB1—Pravastatin—coronary artery disease	0.0221	0.0472	CbGbCtD
Amantadine—ABCB1—Atorvastatin—coronary artery disease	0.0202	0.043	CbGbCtD
Amantadine—ABCB1—Losartan—coronary artery disease	0.0184	0.0393	CbGbCtD
Amantadine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000177	0.000545	CcSEcCtD
Amantadine—Fatigue—Furosemide—coronary artery disease	0.000177	0.000544	CcSEcCtD
Amantadine—Tremor—Lisinopril—coronary artery disease	0.000177	0.000544	CcSEcCtD
Amantadine—Body temperature increased—Telmisartan—coronary artery disease	0.000177	0.000544	CcSEcCtD
Amantadine—Dyspnoea—Losartan—coronary artery disease	0.000177	0.000543	CcSEcCtD
Amantadine—Anxiety—Ramipril—coronary artery disease	0.000177	0.000543	CcSEcCtD
Amantadine—Vomiting—Lovastatin—coronary artery disease	0.000176	0.000542	CcSEcCtD
Amantadine—Somnolence—Losartan—coronary artery disease	0.000176	0.000542	CcSEcCtD
Amantadine—Dizziness—Eplerenone—coronary artery disease	0.000176	0.000541	CcSEcCtD
Amantadine—Rash—Clopidogrel—coronary artery disease	0.000176	0.000541	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000176	0.000541	CcSEcCtD
Amantadine—Dermatitis—Clopidogrel—coronary artery disease	0.000176	0.000541	CcSEcCtD
Amantadine—Asthenia—Valsartan—coronary artery disease	0.000176	0.000541	CcSEcCtD
Amantadine—Hypertension—Timolol—coronary artery disease	0.000176	0.00054	CcSEcCtD
Amantadine—Constipation—Furosemide—coronary artery disease	0.000176	0.00054	CcSEcCtD
Amantadine—Hypersensitivity—Niacin—coronary artery disease	0.000176	0.00054	CcSEcCtD
Amantadine—Asthenia—Olmesartan—coronary artery disease	0.000175	0.000538	CcSEcCtD
Amantadine—Headache—Clopidogrel—coronary artery disease	0.000175	0.000538	CcSEcCtD
Amantadine—Rash—Lovastatin—coronary artery disease	0.000175	0.000538	CcSEcCtD
Amantadine—Dermatitis—Lovastatin—coronary artery disease	0.000175	0.000537	CcSEcCtD
Amantadine—Dyspepsia—Losartan—coronary artery disease	0.000175	0.000536	CcSEcCtD
Amantadine—Feeling abnormal—Perindopril—coronary artery disease	0.000174	0.000535	CcSEcCtD
Amantadine—Headache—Lovastatin—coronary artery disease	0.000174	0.000534	CcSEcCtD
Amantadine—Pruritus—Valsartan—coronary artery disease	0.000173	0.000533	CcSEcCtD
Amantadine—Dry mouth—Ramipril—coronary artery disease	0.000173	0.000533	CcSEcCtD
Amantadine—Vomiting—Ezetimibe—coronary artery disease	0.000173	0.000532	CcSEcCtD
Amantadine—Hypersensitivity—Pravastatin—coronary artery disease	0.000173	0.000531	CcSEcCtD
Amantadine—Anxiety—Timolol—coronary artery disease	0.000173	0.000531	CcSEcCtD
Amantadine—Pruritus—Olmesartan—coronary artery disease	0.000173	0.00053	CcSEcCtD
Amantadine—Decreased appetite—Losartan—coronary artery disease	0.000172	0.00053	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000172	0.000529	CcSEcCtD
Amantadine—Body temperature increased—Captopril—coronary artery disease	0.000172	0.000529	CcSEcCtD
Amantadine—Dizziness—Simvastatin—coronary artery disease	0.000172	0.000528	CcSEcCtD
Amantadine—Rash—Ezetimibe—coronary artery disease	0.000172	0.000527	CcSEcCtD
Amantadine—Dermatitis—Ezetimibe—coronary artery disease	0.000171	0.000527	CcSEcCtD
Amantadine—Confusional state—Ramipril—coronary artery disease	0.000171	0.000527	CcSEcCtD
Amantadine—Asthenia—Niacin—coronary artery disease	0.000171	0.000526	CcSEcCtD
Amantadine—Fatigue—Losartan—coronary artery disease	0.000171	0.000525	CcSEcCtD
Amantadine—Headache—Ezetimibe—coronary artery disease	0.000171	0.000524	CcSEcCtD
Amantadine—Anaphylactic shock—Ramipril—coronary artery disease	0.00017	0.000522	CcSEcCtD
Amantadine—Oedema—Ramipril—coronary artery disease	0.00017	0.000522	CcSEcCtD
Amantadine—Dry mouth—Timolol—coronary artery disease	0.00017	0.000521	CcSEcCtD
Amantadine—Constipation—Losartan—coronary artery disease	0.00017	0.000521	CcSEcCtD
Amantadine—Vomiting—Eplerenone—coronary artery disease	0.000169	0.000521	CcSEcCtD
Amantadine—Feeling abnormal—Furosemide—coronary artery disease	0.000169	0.00052	CcSEcCtD
Amantadine—Leukopenia—Lisinopril—coronary artery disease	0.000169	0.00052	CcSEcCtD
Amantadine—Nausea—Fenofibrate—coronary artery disease	0.000169	0.000519	CcSEcCtD
Amantadine—Pruritus—Niacin—coronary artery disease	0.000169	0.000518	CcSEcCtD
Amantadine—Asthenia—Pravastatin—coronary artery disease	0.000168	0.000517	CcSEcCtD
Amantadine—Rash—Eplerenone—coronary artery disease	0.000168	0.000516	CcSEcCtD
Amantadine—Hypersensitivity—Trandolapril—coronary artery disease	0.000168	0.000516	CcSEcCtD
Amantadine—Dermatitis—Eplerenone—coronary artery disease	0.000168	0.000516	CcSEcCtD
Amantadine—Diarrhoea—Valsartan—coronary artery disease	0.000168	0.000515	CcSEcCtD
Amantadine—Confusional state—Timolol—coronary artery disease	0.000168	0.000515	CcSEcCtD
Amantadine—Hypersensitivity—Enalapril—coronary artery disease	0.000167	0.000514	CcSEcCtD
Amantadine—Body temperature increased—Perindopril—coronary artery disease	0.000167	0.000513	CcSEcCtD
Amantadine—Palpitations—Lisinopril—coronary artery disease	0.000167	0.000513	CcSEcCtD
Amantadine—Diarrhoea—Olmesartan—coronary artery disease	0.000167	0.000513	CcSEcCtD
Amantadine—Headache—Eplerenone—coronary artery disease	0.000167	0.000513	CcSEcCtD
Amantadine—Nervous system disorder—Ramipril—coronary artery disease	0.000167	0.000512	CcSEcCtD
Amantadine—Oedema—Timolol—coronary artery disease	0.000166	0.000511	CcSEcCtD
Amantadine—Anaphylactic shock—Timolol—coronary artery disease	0.000166	0.000511	CcSEcCtD
Amantadine—Pruritus—Pravastatin—coronary artery disease	0.000166	0.00051	CcSEcCtD
Amantadine—Nausea—Clopidogrel—coronary artery disease	0.000166	0.00051	CcSEcCtD
Amantadine—Tachycardia—Ramipril—coronary artery disease	0.000166	0.00051	CcSEcCtD
Amantadine—Skin disorder—Ramipril—coronary artery disease	0.000165	0.000507	CcSEcCtD
Amantadine—Vomiting—Simvastatin—coronary artery disease	0.000165	0.000507	CcSEcCtD
Amantadine—Hypersensitivity—Telmisartan—coronary artery disease	0.000165	0.000507	CcSEcCtD
Amantadine—Nausea—Lovastatin—coronary artery disease	0.000165	0.000507	CcSEcCtD
Amantadine—Hyperhidrosis—Ramipril—coronary artery disease	0.000164	0.000505	CcSEcCtD
Amantadine—Rash—Simvastatin—coronary artery disease	0.000164	0.000503	CcSEcCtD
Amantadine—Dermatitis—Simvastatin—coronary artery disease	0.000164	0.000503	CcSEcCtD
Amantadine—Asthenia—Trandolapril—coronary artery disease	0.000164	0.000502	CcSEcCtD
Amantadine—Feeling abnormal—Losartan—coronary artery disease	0.000163	0.000502	CcSEcCtD
Amantadine—Diarrhoea—Niacin—coronary artery disease	0.000163	0.000501	CcSEcCtD
Amantadine—Nervous system disorder—Timolol—coronary artery disease	0.000163	0.000501	CcSEcCtD
Amantadine—Asthenia—Enalapril—coronary artery disease	0.000163	0.0005	CcSEcCtD
Amantadine—Headache—Simvastatin—coronary artery disease	0.000163	0.0005	CcSEcCtD
Amantadine—Body temperature increased—Furosemide—coronary artery disease	0.000162	0.000499	CcSEcCtD
Amantadine—Dizziness—Valsartan—coronary artery disease	0.000162	0.000498	CcSEcCtD
Amantadine—Anorexia—Ramipril—coronary artery disease	0.000162	0.000498	CcSEcCtD
Amantadine—Nausea—Ezetimibe—coronary artery disease	0.000162	0.000497	CcSEcCtD
Amantadine—Skin disorder—Timolol—coronary artery disease	0.000161	0.000496	CcSEcCtD
Amantadine—Dizziness—Olmesartan—coronary artery disease	0.000161	0.000496	CcSEcCtD
Amantadine—Pruritus—Trandolapril—coronary artery disease	0.000161	0.000495	CcSEcCtD
Amantadine—Hyperhidrosis—Timolol—coronary artery disease	0.000161	0.000494	CcSEcCtD
Amantadine—Asthenia—Telmisartan—coronary artery disease	0.000161	0.000494	CcSEcCtD
Amantadine—Pruritus—Enalapril—coronary artery disease	0.000161	0.000494	CcSEcCtD
Amantadine—Diarrhoea—Pravastatin—coronary artery disease	0.000161	0.000493	CcSEcCtD
Amantadine—Anxiety—Lisinopril—coronary artery disease	0.00016	0.000493	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.00016	0.000491	CcSEcCtD
Amantadine—Hypotension—Ramipril—coronary artery disease	0.000159	0.000488	CcSEcCtD
Amantadine—Anorexia—Timolol—coronary artery disease	0.000158	0.000487	CcSEcCtD
Amantadine—Pruritus—Telmisartan—coronary artery disease	0.000158	0.000487	CcSEcCtD
Amantadine—Nausea—Eplerenone—coronary artery disease	0.000158	0.000486	CcSEcCtD
Amantadine—Dizziness—Niacin—coronary artery disease	0.000158	0.000484	CcSEcCtD
Amantadine—Dry mouth—Lisinopril—coronary artery disease	0.000157	0.000483	CcSEcCtD
Amantadine—Body temperature increased—Losartan—coronary artery disease	0.000157	0.000482	CcSEcCtD
Amantadine—Asthenia—Captopril—coronary artery disease	0.000156	0.00048	CcSEcCtD
Amantadine—Diarrhoea—Trandolapril—coronary artery disease	0.000156	0.000479	CcSEcCtD
Amantadine—Vomiting—Valsartan—coronary artery disease	0.000156	0.000479	CcSEcCtD
Amantadine—Confusional state—Lisinopril—coronary artery disease	0.000155	0.000478	CcSEcCtD
Amantadine—Diarrhoea—Enalapril—coronary artery disease	0.000155	0.000477	CcSEcCtD
Amantadine—Hypotension—Timolol—coronary artery disease	0.000155	0.000477	CcSEcCtD
Amantadine—Dizziness—Pravastatin—coronary artery disease	0.000155	0.000477	CcSEcCtD
Amantadine—Vomiting—Olmesartan—coronary artery disease	0.000155	0.000477	CcSEcCtD
Amantadine—Rash—Valsartan—coronary artery disease	0.000155	0.000475	CcSEcCtD
Amantadine—Dermatitis—Valsartan—coronary artery disease	0.000154	0.000475	CcSEcCtD
Amantadine—Nausea—Simvastatin—coronary artery disease	0.000154	0.000474	CcSEcCtD
Amantadine—Oedema—Lisinopril—coronary artery disease	0.000154	0.000474	CcSEcCtD
Amantadine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000154	0.000474	CcSEcCtD
Amantadine—Pruritus—Captopril—coronary artery disease	0.000154	0.000473	CcSEcCtD
Amantadine—Rash—Olmesartan—coronary artery disease	0.000154	0.000473	CcSEcCtD
Amantadine—Insomnia—Ramipril—coronary artery disease	0.000154	0.000473	CcSEcCtD
Amantadine—Dermatitis—Olmesartan—coronary artery disease	0.000154	0.000472	CcSEcCtD
Amantadine—Headache—Valsartan—coronary artery disease	0.000154	0.000472	CcSEcCtD
Amantadine—Diarrhoea—Telmisartan—coronary artery disease	0.000153	0.000471	CcSEcCtD
Amantadine—Headache—Olmesartan—coronary artery disease	0.000153	0.00047	CcSEcCtD
Amantadine—Paraesthesia—Ramipril—coronary artery disease	0.000153	0.000469	CcSEcCtD
Amantadine—Asthenia—Perindopril—coronary artery disease	0.000152	0.000466	CcSEcCtD
Amantadine—Dyspnoea—Ramipril—coronary artery disease	0.000152	0.000466	CcSEcCtD
Amantadine—Vomiting—Niacin—coronary artery disease	0.000152	0.000466	CcSEcCtD
Amantadine—Hypersensitivity—Furosemide—coronary artery disease	0.000151	0.000465	CcSEcCtD
Amantadine—Somnolence—Ramipril—coronary artery disease	0.000151	0.000464	CcSEcCtD
Amantadine—Dizziness—Trandolapril—coronary artery disease	0.000151	0.000463	CcSEcCtD
Amantadine—Tachycardia—Lisinopril—coronary artery disease	0.00015	0.000462	CcSEcCtD
Amantadine—Insomnia—Timolol—coronary artery disease	0.00015	0.000462	CcSEcCtD
Amantadine—Rash—Niacin—coronary artery disease	0.00015	0.000462	CcSEcCtD
Amantadine—Dermatitis—Niacin—coronary artery disease	0.00015	0.000461	CcSEcCtD
Amantadine—Dizziness—Enalapril—coronary artery disease	0.00015	0.000461	CcSEcCtD
Amantadine—Skin disorder—Lisinopril—coronary artery disease	0.00015	0.00046	CcSEcCtD
Amantadine—Dyspepsia—Ramipril—coronary artery disease	0.00015	0.00046	CcSEcCtD
Amantadine—Pruritus—Perindopril—coronary artery disease	0.00015	0.00046	CcSEcCtD
Amantadine—Headache—Niacin—coronary artery disease	0.000149	0.000459	CcSEcCtD
Amantadine—Paraesthesia—Timolol—coronary artery disease	0.000149	0.000459	CcSEcCtD
Amantadine—Vomiting—Pravastatin—coronary artery disease	0.000149	0.000459	CcSEcCtD
Amantadine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000149	0.000458	CcSEcCtD
Amantadine—Diarrhoea—Captopril—coronary artery disease	0.000149	0.000458	CcSEcCtD
Amantadine—Dyspnoea—Timolol—coronary artery disease	0.000148	0.000455	CcSEcCtD
Amantadine—Dizziness—Telmisartan—coronary artery disease	0.000148	0.000455	CcSEcCtD
Amantadine—Rash—Pravastatin—coronary artery disease	0.000148	0.000455	CcSEcCtD
Amantadine—Dermatitis—Pravastatin—coronary artery disease	0.000148	0.000454	CcSEcCtD
Amantadine—Decreased appetite—Ramipril—coronary artery disease	0.000148	0.000454	CcSEcCtD
Amantadine—Somnolence—Timolol—coronary artery disease	0.000148	0.000454	CcSEcCtD
Amantadine—Asthenia—Furosemide—coronary artery disease	0.000147	0.000453	CcSEcCtD
Amantadine—Headache—Pravastatin—coronary artery disease	0.000147	0.000452	CcSEcCtD
Amantadine—Anorexia—Lisinopril—coronary artery disease	0.000147	0.000452	CcSEcCtD
Amantadine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000147	0.000451	CcSEcCtD
Amantadine—Fatigue—Ramipril—coronary artery disease	0.000147	0.00045	CcSEcCtD
Amantadine—Dyspepsia—Timolol—coronary artery disease	0.000146	0.00045	CcSEcCtD
Amantadine—Hypersensitivity—Losartan—coronary artery disease	0.000146	0.000449	CcSEcCtD
Amantadine—Nausea—Valsartan—coronary artery disease	0.000146	0.000447	CcSEcCtD
Amantadine—Pruritus—Furosemide—coronary artery disease	0.000145	0.000447	CcSEcCtD
Amantadine—Constipation—Ramipril—coronary artery disease	0.000145	0.000447	CcSEcCtD
Amantadine—Nausea—Olmesartan—coronary artery disease	0.000145	0.000445	CcSEcCtD
Amantadine—Vomiting—Trandolapril—coronary artery disease	0.000145	0.000445	CcSEcCtD
Amantadine—Diarrhoea—Perindopril—coronary artery disease	0.000145	0.000444	CcSEcCtD
Amantadine—Decreased appetite—Timolol—coronary artery disease	0.000144	0.000444	CcSEcCtD
Amantadine—Vomiting—Enalapril—coronary artery disease	0.000144	0.000444	CcSEcCtD
Amantadine—Hypotension—Lisinopril—coronary artery disease	0.000144	0.000443	CcSEcCtD
Amantadine—Dizziness—Captopril—coronary artery disease	0.000144	0.000442	CcSEcCtD
Amantadine—Rash—Trandolapril—coronary artery disease	0.000144	0.000442	CcSEcCtD
Amantadine—Dermatitis—Trandolapril—coronary artery disease	0.000144	0.000441	CcSEcCtD
Amantadine—Gastrointestinal disorder—Timolol—coronary artery disease	0.000143	0.000441	CcSEcCtD
Amantadine—Fatigue—Timolol—coronary artery disease	0.000143	0.00044	CcSEcCtD
Amantadine—Rash—Enalapril—coronary artery disease	0.000143	0.00044	CcSEcCtD
Amantadine—Dermatitis—Enalapril—coronary artery disease	0.000143	0.000439	CcSEcCtD
Amantadine—Headache—Trandolapril—coronary artery disease	0.000143	0.000439	CcSEcCtD
Amantadine—Vomiting—Telmisartan—coronary artery disease	0.000142	0.000437	CcSEcCtD
Amantadine—Asthenia—Losartan—coronary artery disease	0.000142	0.000437	CcSEcCtD
Amantadine—Headache—Enalapril—coronary artery disease	0.000142	0.000437	CcSEcCtD
Amantadine—Nausea—Niacin—coronary artery disease	0.000142	0.000435	CcSEcCtD
Amantadine—Rash—Telmisartan—coronary artery disease	0.000141	0.000434	CcSEcCtD
Amantadine—Dermatitis—Telmisartan—coronary artery disease	0.000141	0.000433	CcSEcCtD
Amantadine—Diarrhoea—Furosemide—coronary artery disease	0.000141	0.000432	CcSEcCtD
Amantadine—Pruritus—Losartan—coronary artery disease	0.00014	0.000431	CcSEcCtD
Amantadine—Headache—Telmisartan—coronary artery disease	0.00014	0.000431	CcSEcCtD
Amantadine—Feeling abnormal—Ramipril—coronary artery disease	0.00014	0.000431	CcSEcCtD
Amantadine—Dizziness—Perindopril—coronary artery disease	0.00014	0.00043	CcSEcCtD
Amantadine—Insomnia—Lisinopril—coronary artery disease	0.000139	0.000429	CcSEcCtD
Amantadine—Nausea—Pravastatin—coronary artery disease	0.000139	0.000428	CcSEcCtD
Amantadine—Paraesthesia—Lisinopril—coronary artery disease	0.000138	0.000425	CcSEcCtD
Amantadine—Vomiting—Captopril—coronary artery disease	0.000138	0.000425	CcSEcCtD
Amantadine—Dyspnoea—Lisinopril—coronary artery disease	0.000137	0.000422	CcSEcCtD
Amantadine—Rash—Captopril—coronary artery disease	0.000137	0.000422	CcSEcCtD
Amantadine—Dermatitis—Captopril—coronary artery disease	0.000137	0.000421	CcSEcCtD
Amantadine—Somnolence—Lisinopril—coronary artery disease	0.000137	0.000421	CcSEcCtD
Amantadine—Feeling abnormal—Timolol—coronary artery disease	0.000137	0.000421	CcSEcCtD
Amantadine—Headache—Captopril—coronary artery disease	0.000136	0.000419	CcSEcCtD
Amantadine—Dizziness—Furosemide—coronary artery disease	0.000136	0.000418	CcSEcCtD
Amantadine—Dyspepsia—Lisinopril—coronary artery disease	0.000136	0.000417	CcSEcCtD
Amantadine—Diarrhoea—Losartan—coronary artery disease	0.000136	0.000417	CcSEcCtD
Amantadine—Nausea—Trandolapril—coronary artery disease	0.000135	0.000416	CcSEcCtD
Amantadine—Nausea—Enalapril—coronary artery disease	0.000135	0.000414	CcSEcCtD
Amantadine—Vomiting—Perindopril—coronary artery disease	0.000134	0.000413	CcSEcCtD
Amantadine—Body temperature increased—Ramipril—coronary artery disease	0.000134	0.000413	CcSEcCtD
Amantadine—Decreased appetite—Lisinopril—coronary artery disease	0.000134	0.000412	CcSEcCtD
Amantadine—Rash—Perindopril—coronary artery disease	0.000133	0.00041	CcSEcCtD
Amantadine—Dermatitis—Perindopril—coronary artery disease	0.000133	0.000409	CcSEcCtD
Amantadine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000133	0.000409	CcSEcCtD
Amantadine—Nausea—Telmisartan—coronary artery disease	0.000133	0.000409	CcSEcCtD
Amantadine—Fatigue—Lisinopril—coronary artery disease	0.000133	0.000408	CcSEcCtD
Amantadine—Headache—Perindopril—coronary artery disease	0.000132	0.000407	CcSEcCtD
Amantadine—Constipation—Lisinopril—coronary artery disease	0.000132	0.000405	CcSEcCtD
Amantadine—Body temperature increased—Timolol—coronary artery disease	0.000131	0.000404	CcSEcCtD
Amantadine—Dizziness—Losartan—coronary artery disease	0.000131	0.000403	CcSEcCtD
Amantadine—Vomiting—Furosemide—coronary artery disease	0.000131	0.000401	CcSEcCtD
Amantadine—Rash—Furosemide—coronary artery disease	0.00013	0.000398	CcSEcCtD
Amantadine—Dermatitis—Furosemide—coronary artery disease	0.000129	0.000398	CcSEcCtD
Amantadine—Nausea—Captopril—coronary artery disease	0.000129	0.000397	CcSEcCtD
Amantadine—Headache—Furosemide—coronary artery disease	0.000129	0.000396	CcSEcCtD
Amantadine—Feeling abnormal—Lisinopril—coronary artery disease	0.000127	0.00039	CcSEcCtD
Amantadine—Vomiting—Losartan—coronary artery disease	0.000126	0.000387	CcSEcCtD
Amantadine—Nausea—Perindopril—coronary artery disease	0.000126	0.000386	CcSEcCtD
Amantadine—Hypersensitivity—Ramipril—coronary artery disease	0.000125	0.000385	CcSEcCtD
Amantadine—Rash—Losartan—coronary artery disease	0.000125	0.000384	CcSEcCtD
Amantadine—Dermatitis—Losartan—coronary artery disease	0.000125	0.000384	CcSEcCtD
Amantadine—Headache—Losartan—coronary artery disease	0.000124	0.000382	CcSEcCtD
Amantadine—Hypersensitivity—Timolol—coronary artery disease	0.000122	0.000376	CcSEcCtD
Amantadine—Nausea—Furosemide—coronary artery disease	0.000122	0.000375	CcSEcCtD
Amantadine—Asthenia—Ramipril—coronary artery disease	0.000122	0.000375	CcSEcCtD
Amantadine—Body temperature increased—Lisinopril—coronary artery disease	0.000122	0.000375	CcSEcCtD
Amantadine—Pruritus—Ramipril—coronary artery disease	0.00012	0.00037	CcSEcCtD
Amantadine—Asthenia—Timolol—coronary artery disease	0.000119	0.000366	CcSEcCtD
Amantadine—Nausea—Losartan—coronary artery disease	0.000118	0.000362	CcSEcCtD
Amantadine—Pruritus—Timolol—coronary artery disease	0.000118	0.000361	CcSEcCtD
Amantadine—Diarrhoea—Ramipril—coronary artery disease	0.000116	0.000357	CcSEcCtD
Amantadine—Diarrhoea—Timolol—coronary artery disease	0.000114	0.000349	CcSEcCtD
Amantadine—Hypersensitivity—Lisinopril—coronary artery disease	0.000114	0.000349	CcSEcCtD
Amantadine—Dizziness—Ramipril—coronary artery disease	0.000112	0.000345	CcSEcCtD
Amantadine—Asthenia—Lisinopril—coronary artery disease	0.000111	0.00034	CcSEcCtD
Amantadine—Dizziness—Timolol—coronary artery disease	0.00011	0.000338	CcSEcCtD
Amantadine—Pruritus—Lisinopril—coronary artery disease	0.000109	0.000335	CcSEcCtD
Amantadine—Vomiting—Ramipril—coronary artery disease	0.000108	0.000332	CcSEcCtD
Amantadine—Rash—Ramipril—coronary artery disease	0.000107	0.000329	CcSEcCtD
Amantadine—Dermatitis—Ramipril—coronary artery disease	0.000107	0.000329	CcSEcCtD
Amantadine—Headache—Ramipril—coronary artery disease	0.000107	0.000327	CcSEcCtD
Amantadine—Vomiting—Timolol—coronary artery disease	0.000106	0.000325	CcSEcCtD
Amantadine—Diarrhoea—Lisinopril—coronary artery disease	0.000106	0.000324	CcSEcCtD
Amantadine—Rash—Timolol—coronary artery disease	0.000105	0.000322	CcSEcCtD
Amantadine—Dermatitis—Timolol—coronary artery disease	0.000105	0.000322	CcSEcCtD
Amantadine—Headache—Timolol—coronary artery disease	0.000104	0.00032	CcSEcCtD
Amantadine—Dizziness—Lisinopril—coronary artery disease	0.000102	0.000313	CcSEcCtD
Amantadine—Nausea—Ramipril—coronary artery disease	0.000101	0.00031	CcSEcCtD
Amantadine—Nausea—Timolol—coronary artery disease	9.87e-05	0.000303	CcSEcCtD
Amantadine—Vomiting—Lisinopril—coronary artery disease	9.8e-05	0.000301	CcSEcCtD
Amantadine—Rash—Lisinopril—coronary artery disease	9.72e-05	0.000299	CcSEcCtD
Amantadine—Dermatitis—Lisinopril—coronary artery disease	9.71e-05	0.000298	CcSEcCtD
Amantadine—Headache—Lisinopril—coronary artery disease	9.66e-05	0.000297	CcSEcCtD
Amantadine—Nausea—Lisinopril—coronary artery disease	9.16e-05	0.000281	CcSEcCtD
Amantadine—ABCB1—Metabolism—PDHA1—coronary artery disease	1.2e-05	5.82e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCLM—coronary artery disease	1.2e-05	5.82e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PLCB1—coronary artery disease	1.19e-05	5.78e-05	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.18e-05	5.74e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EDN1—coronary artery disease	1.16e-05	5.66e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—coronary artery disease	1.16e-05	5.65e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP11B2—coronary artery disease	1.16e-05	5.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—TXNRD1—coronary artery disease	1.16e-05	5.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCL5—coronary artery disease	1.15e-05	5.61e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	1.15e-05	5.6e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ABCA1—coronary artery disease	1.15e-05	5.6e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PRKCD—coronary artery disease	1.14e-05	5.57e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC22A3—coronary artery disease	1.14e-05	5.55e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CSF2—coronary artery disease	1.14e-05	5.53e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ARNTL—coronary artery disease	1.13e-05	5.47e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HADH—coronary artery disease	1.13e-05	5.47e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCR3—coronary artery disease	1.12e-05	5.45e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—HTR2A—coronary artery disease	1.12e-05	5.45e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—C3—coronary artery disease	1.12e-05	5.44e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ALB—coronary artery disease	1.12e-05	5.43e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GGT1—coronary artery disease	1.11e-05	5.42e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GOT1—coronary artery disease	1.11e-05	5.42e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PLCB1—coronary artery disease	1.11e-05	5.38e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CRK—coronary artery disease	1.11e-05	5.38e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOB—coronary artery disease	1.1e-05	5.37e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	1.1e-05	5.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SH2B3—coronary artery disease	1.09e-05	5.31e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ATP2A2—coronary artery disease	1.09e-05	5.31e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VWF—coronary artery disease	1.09e-05	5.31e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOC3—coronary artery disease	1.09e-05	5.28e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	1.08e-05	5.26e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LDLR—coronary artery disease	1.08e-05	5.25e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCA1—coronary artery disease	1.07e-05	5.22e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—NOS3—coronary artery disease	1.07e-05	5.2e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GPX2—coronary artery disease	1.07e-05	5.19e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLA2G2A—coronary artery disease	1.07e-05	5.19e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA2—coronary artery disease	1.07e-05	5.19e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AGT—coronary artery disease	1.06e-05	5.17e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PPP2CA—coronary artery disease	1.06e-05	5.15e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HK1—coronary artery disease	1.05e-05	5.13e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GPX4—coronary artery disease	1.05e-05	5.13e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ABCG5—coronary artery disease	1.05e-05	5.13e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SULT1A1—coronary artery disease	1.05e-05	5.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCL3—coronary artery disease	1.05e-05	5.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL2—coronary artery disease	1.05e-05	5.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—F2R—coronary artery disease	1.04e-05	5.07e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SDC1—coronary artery disease	1.04e-05	5.07e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HADHA—coronary artery disease	1.04e-05	5.06e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PRKCD—coronary artery disease	1.04e-05	5.06e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GOT1—coronary artery disease	1.04e-05	5.05e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GGT1—coronary artery disease	1.04e-05	5.05e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTA1—coronary artery disease	1.03e-05	5.01e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	1.03e-05	5e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGB—coronary artery disease	1.02e-05	4.96e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPA—coronary artery disease	1.02e-05	4.95e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HTR2A—coronary artery disease	1.02e-05	4.95e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—C3—coronary artery disease	1.02e-05	4.94e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDNRB—coronary artery disease	1.01e-05	4.91e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTP1—coronary artery disease	1e-05	4.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—THBS1—coronary artery disease	9.94e-06	4.83e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARGC1A—coronary artery disease	9.92e-06	4.83e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—HMOX1—coronary artery disease	9.87e-06	4.8e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLCB3—coronary artery disease	9.85e-06	4.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PSMB5—coronary artery disease	9.84e-06	4.79e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PSMA6—coronary artery disease	9.84e-06	4.79e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—F2—coronary artery disease	9.82e-06	4.78e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—coronary artery disease	9.77e-06	4.75e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA5—coronary artery disease	9.76e-06	4.75e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CAT—coronary artery disease	9.74e-06	4.74e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AGT—coronary artery disease	9.65e-06	4.69e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—P4HB—coronary artery disease	9.57e-06	4.65e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDNRA—coronary artery disease	9.53e-06	4.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CYBA—coronary artery disease	9.49e-06	4.61e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB1—coronary artery disease	9.49e-06	4.61e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOB—coronary artery disease	9.46e-06	4.6e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—DUSP6—coronary artery disease	9.44e-06	4.59e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLA2G1B—coronary artery disease	9.39e-06	4.57e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	9.37e-06	4.56e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTP1—coronary artery disease	9.33e-06	4.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLAT—coronary artery disease	9.28e-06	4.52e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARGC1A—coronary artery disease	9.24e-06	4.5e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—HMOX1—coronary artery disease	9.2e-06	4.48e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GSTM1—coronary artery disease	9.2e-06	4.48e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CAT—coronary artery disease	9.08e-06	4.42e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—LPL—coronary artery disease	9.03e-06	4.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL12—coronary artery disease	8.96e-06	4.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BDKRB2—coronary artery disease	8.96e-06	4.36e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—POMC—coronary artery disease	8.94e-06	4.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—F2—coronary artery disease	8.92e-06	4.34e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6ST—coronary artery disease	8.88e-06	4.32e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—VCAN—coronary artery disease	8.85e-06	4.31e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOB—coronary artery disease	8.81e-06	4.29e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GPX1—coronary artery disease	8.81e-06	4.29e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JUNB—coronary artery disease	8.79e-06	4.28e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALDOA—coronary artery disease	8.78e-06	4.27e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLCB1—coronary artery disease	8.76e-06	4.26e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	8.73e-06	4.25e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CD36—coronary artery disease	8.58e-06	4.17e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR7—coronary artery disease	8.58e-06	4.17e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GSTM1—coronary artery disease	8.57e-06	4.17e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—DCN—coronary artery disease	8.53e-06	4.15e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPP2CA—coronary artery disease	8.47e-06	4.12e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—LPL—coronary artery disease	8.42e-06	4.09e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALDH2—coronary artery disease	8.3e-06	4.04e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GPX1—coronary artery disease	8.21e-06	3.99e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ITGAV—coronary artery disease	8.17e-06	3.98e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KNG1—coronary artery disease	8.15e-06	3.96e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MTHFR—coronary artery disease	8.13e-06	3.96e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CREB1—coronary artery disease	8.12e-06	3.95e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—POMC—coronary artery disease	8.12e-06	3.95e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGTR1—coronary artery disease	8.1e-06	3.94e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CYP2C19—coronary artery disease	8.08e-06	3.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3C2A—coronary artery disease	8.08e-06	3.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HBA1—coronary artery disease	8.08e-06	3.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LIPC—coronary artery disease	8.08e-06	3.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOC3—coronary artery disease	8.03e-06	3.91e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CD36—coronary artery disease	8e-06	3.89e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LDLR—coronary artery disease	7.98e-06	3.88e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CCL2—coronary artery disease	7.95e-06	3.87e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6R—coronary artery disease	7.92e-06	3.85e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL10—coronary artery disease	7.92e-06	3.85e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPP2CA—coronary artery disease	7.9e-06	3.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PLG—coronary artery disease	7.89e-06	3.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC9A1—coronary artery disease	7.89e-06	3.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTT1—coronary artery disease	7.89e-06	3.84e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GCLC—coronary artery disease	7.8e-06	3.79e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CETP—coronary artery disease	7.8e-06	3.79e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AGT—coronary artery disease	7.72e-06	3.76e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SDC1—coronary artery disease	7.71e-06	3.75e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ADRB2—coronary artery disease	7.69e-06	3.74e-05	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	7.66e-06	3.73e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKCE—coronary artery disease	7.59e-06	3.69e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—JAK2—coronary artery disease	7.58e-06	3.69e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MTHFR—coronary artery disease	7.58e-06	3.69e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOE—coronary artery disease	7.57e-06	3.68e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SOCS1—coronary artery disease	7.57e-06	3.68e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—S100B—coronary artery disease	7.55e-06	3.67e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—APOA1—coronary artery disease	7.48e-06	3.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SOCS3—coronary artery disease	7.48e-06	3.64e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFBR2—coronary artery disease	7.39e-06	3.59e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KITLG—coronary artery disease	7.39e-06	3.59e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PSMA6—coronary artery disease	7.29e-06	3.54e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PSMB5—coronary artery disease	7.29e-06	3.54e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP3—coronary artery disease	7.22e-06	3.51e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—STAT5A—coronary artery disease	7.22e-06	3.51e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AGT—coronary artery disease	7.2e-06	3.5e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—PIK3CA—coronary artery disease	7.14e-06	3.48e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CTGF—coronary artery disease	7.12e-06	3.46e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOE—coronary artery disease	7.05e-06	3.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GOT2—coronary artery disease	7.05e-06	3.43e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMGCR—coronary artery disease	7.05e-06	3.43e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOB—coronary artery disease	6.98e-06	3.4e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—APOA1—coronary artery disease	6.97e-06	3.39e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CXCL8—coronary artery disease	6.92e-06	3.37e-05	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	6.91e-06	3.36e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—JAK2—coronary artery disease	6.88e-06	3.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EDN1—coronary artery disease	6.87e-06	3.34e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCL5—coronary artery disease	6.81e-06	3.32e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CSF2—coronary artery disease	6.71e-06	3.27e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGF1—coronary artery disease	6.71e-06	3.27e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LPL—coronary artery disease	6.66e-06	3.24e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MEF2C—coronary artery disease	6.6e-06	3.21e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—RPS6KB1—coronary artery disease	6.6e-06	3.21e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PPARG—coronary artery disease	6.59e-06	3.21e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—POMC—coronary artery disease	6.5e-06	3.16e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PLCB1—coronary artery disease	6.49e-06	3.16e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ITGB3—coronary artery disease	6.44e-06	3.13e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ABCA1—coronary artery disease	6.29e-06	3.06e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CXCL8—coronary artery disease	6.28e-06	3.06e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PPP2CA—coronary artery disease	6.25e-06	3.04e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PPARG—coronary artery disease	6.14e-06	2.99e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKCD—coronary artery disease	6.14e-06	2.99e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GGT1—coronary artery disease	6.09e-06	2.96e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GOT1—coronary artery disease	6.09e-06	2.96e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—POMC—coronary artery disease	6.06e-06	2.95e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PIK3CA—coronary artery disease	6.01e-06	2.93e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HTR2A—coronary artery disease	6.01e-06	2.92e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—C3—coronary artery disease	6e-06	2.92e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ALB—coronary artery disease	5.93e-06	2.88e-05	CbGpPWpGaD
Amantadine—DDC—Metabolism—AKT1—coronary artery disease	5.84e-06	2.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HIF1A—coronary artery disease	5.72e-06	2.78e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AGT—coronary artery disease	5.7e-06	2.77e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—NOS3—coronary artery disease	5.67e-06	2.76e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOE—coronary artery disease	5.59e-06	2.72e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—LEP—coronary artery disease	5.59e-06	2.72e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ALB—coronary artery disease	5.53e-06	2.69e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—APOA1—coronary artery disease	5.52e-06	2.69e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KDR—coronary artery disease	5.47e-06	2.66e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTP1—coronary artery disease	5.47e-06	2.66e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK14—coronary artery disease	5.44e-06	2.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARGC1A—coronary artery disease	5.42e-06	2.64e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—HMOX1—coronary artery disease	5.39e-06	2.62e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ESR1—coronary artery disease	5.33e-06	2.59e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CAT—coronary artery disease	5.32e-06	2.59e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—NOS3—coronary artery disease	5.29e-06	2.57e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—F2—coronary artery disease	5.27e-06	2.56e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FN1—coronary artery disease	5.27e-06	2.56e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6ST—coronary artery disease	5.25e-06	2.55e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	5.2e-06	2.53e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—coronary artery disease	5.19e-06	2.52e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOB—coronary artery disease	5.17e-06	2.51e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KIT—coronary artery disease	5.04e-06	2.45e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GSTM1—coronary artery disease	5.03e-06	2.44e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—LPL—coronary artery disease	4.93e-06	2.4e-05	CbGpPWpGaD
Amantadine—MAOB—Metabolism—AKT1—coronary artery disease	4.91e-06	2.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GSK3B—coronary artery disease	4.84e-06	2.35e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—coronary artery disease	4.83e-06	2.35e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GPX1—coronary artery disease	4.81e-06	2.34e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—POMC—coronary artery disease	4.8e-06	2.33e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CREB1—coronary artery disease	4.8e-06	2.33e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCL2—coronary artery disease	4.69e-06	2.28e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CD36—coronary artery disease	4.69e-06	2.28e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6R—coronary artery disease	4.68e-06	2.28e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPP2CA—coronary artery disease	4.63e-06	2.25e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1—coronary artery disease	4.62e-06	2.25e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	4.59e-06	2.23e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MTHFR—coronary artery disease	4.44e-06	2.16e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.39e-06	2.14e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	4.38e-06	2.13e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGF2—coronary artery disease	4.24e-06	2.06e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AGT—coronary artery disease	4.22e-06	2.05e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NOS3—coronary artery disease	4.18e-06	2.04e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOE—coronary artery disease	4.13e-06	2.01e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—APOA1—coronary artery disease	4.09e-06	1.99e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—JAK2—coronary artery disease	4.07e-06	1.98e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	3.99e-06	1.94e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	3.71e-06	1.81e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PPARG—coronary artery disease	3.6e-06	1.75e-05	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	3.59e-06	1.74e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CASP3—coronary artery disease	3.55e-06	1.73e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—POMC—coronary artery disease	3.55e-06	1.73e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—IL6—coronary artery disease	3.53e-06	1.72e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CCND1—coronary artery disease	3.46e-06	1.68e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MMP9—coronary artery disease	3.36e-06	1.63e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	3.26e-06	1.58e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—ALB—coronary artery disease	3.24e-06	1.58e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PIK3CA—coronary artery disease	3.19e-06	1.55e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—NOS3—coronary artery disease	3.1e-06	1.51e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	3.01e-06	1.47e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PIK3CA—coronary artery disease	2.97e-06	1.45e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—coronary artery disease	2.83e-06	1.38e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	2.77e-06	1.35e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	2.71e-06	1.32e-05	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—AKT1—coronary artery disease	2.61e-06	1.27e-05	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—AKT1—coronary artery disease	2.43e-06	1.18e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	2.35e-06	1.15e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IL6—coronary artery disease	2.09e-06	1.01e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AKT1—coronary artery disease	1.92e-06	9.36e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.74e-06	8.48e-06	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—AKT1—coronary artery disease	1.42e-06	6.93e-06	CbGpPWpGaD
